Antifibrotic Soluble Thy-1 Correlates with Renal Dysfunction in Chronic Kidney Disease.
Thy-1
chronic kidney disease
fibrosis
renal dysfunction
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
18 Jan 2023
18 Jan 2023
Historique:
received:
01
12
2022
revised:
12
01
2023
accepted:
12
01
2023
entrez:
11
2
2023
pubmed:
12
2
2023
medline:
15
2
2023
Statut:
epublish
Résumé
Kidney fibrosis is a major culprit in the development and progression of chronic kidney disease (CKD), ultimately leading to the irreversible loss of organ function. Thymocyte differentiation antigen-1 (Thy-1) controls many core functions of fibroblasts relevant to fibrogenesis but is also found in a soluble form (sThy-1) in serum and urine. We investigated the association of sThy-1 with clinical parameters in patients with CKD receiving hemodialysis treatment compared to individuals with a preserved renal function. Furthermore, Thy-1 tissue expression was detected in a mouse model of diabetic CKD (eNOS
Identifiants
pubmed: 36768219
pii: ijms24031896
doi: 10.3390/ijms24031896
pmc: PMC9916214
pii:
doi:
Substances chimiques
Creatinine
AYI8EX34EU
Thy-1 Antigens
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : SA 863/9-1
Références
Lancet. 2010 Jun 12;375(9731):2073-81
pubmed: 20483451
J Cell Physiol. 1996 Sep;168(3):705-10
pubmed: 8816925
BMC Nephrol. 2018 Oct 22;19(1):285
pubmed: 30348110
Antioxid Redox Signal. 2021 Dec 10;35(17):1426-1448
pubmed: 34006115
J Invest Dermatol. 2015 Jul;135(7):1893-1902
pubmed: 25739049
Lancet. 2020 Feb 29;395(10225):709-733
pubmed: 32061315
Nephrol Dial Transplant. 2017 Oct 01;32(10):1637-1644
pubmed: 28339962
Am J Physiol Renal Physiol. 2019 May 1;316(5):F889-F897
pubmed: 30810354
Ann Intern Med. 2013 Jun 4;158(11):825-30
pubmed: 23732715
Eur J Endocrinol. 2020 Sep;183(3):233-244
pubmed: 32508317
Ann Transl Med. 2021 Feb;9(4):282
pubmed: 33708909
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):
pubmed: 34253615
J Clin Invest. 2017 Apr 3;127(4):1254-1270
pubmed: 28287406
J Cell Biol. 2015 Oct 12;211(1):173-90
pubmed: 26459603
Am J Respir Cell Mol Biol. 2009 Feb;40(2):231-8
pubmed: 18676775
Arch Dermatol Res. 1998 Jul;290(7):360-6
pubmed: 9749990
Am J Respir Cell Mol Biol. 2007 Feb;36(2):226-35
pubmed: 16960126
Am J Pathol. 2004 Aug;165(2):659-69
pubmed: 15277239
Biomaterials. 2020 Apr;236:119824
pubmed: 32028169
Differentiation. 2020 May - Jun;113:38-48
pubmed: 32403041
Am J Pathol. 2005 Aug;167(2):365-79
pubmed: 16049324
FASEB J. 2019 Jun;33(6):6689-6696
pubmed: 30811954
J Biol Chem. 1988 Sep 5;263(25):12709-15
pubmed: 2900838
N Engl J Med. 2004 Sep 23;351(13):1296-305
pubmed: 15385656
Cell Tissue Res. 1999 Nov;298(2):307-15
pubmed: 10571119
J Am Soc Nephrol. 2006 Oct;17(10):2664-9
pubmed: 16971655
Mol Aspects Med. 2022 Aug;86:101099
pubmed: 35689974
Front Cell Dev Biol. 2019 Jul 26;7:132
pubmed: 31428610
Lab Invest. 2017 Mar;97(3):256-267
pubmed: 28165468
Arthritis Care Res (Hoboken). 2013 Feb;65(2):281-7
pubmed: 22807289
Int J Mol Sci. 2021 Jan 02;22(1):
pubmed: 33401711
Toxins (Basel). 2020 Apr 04;12(4):
pubmed: 32260373
Lab Invest. 2011 Aug;91(8):1206-18
pubmed: 21577212
Diabetes Metab. 2017 Oct;43(5):465-468
pubmed: 28214129
Biofactors. 2009 May-Jun;35(3):258-65
pubmed: 19422052
Front Cell Dev Biol. 2022 Jun 06;10:928510
pubmed: 35733855
Int J Mol Sci. 2020 Dec 22;22(1):
pubmed: 33375198
Scand J Clin Lab Invest. 2004;64(8):709-22
pubmed: 15719889
Front Cell Dev Biol. 2018 Dec 18;6:173
pubmed: 30619853
J Biol Chem. 2010 Jul 16;285(29):22382-93
pubmed: 20463011
Eur J Endocrinol. 2019 Aug;181(2):151-159
pubmed: 31153139
Nat Rev Nephrol. 2020 May;16(5):269-288
pubmed: 32060481
Cell Cycle. 2019 Mar - Apr;18(6-7):670-681
pubmed: 30829553
J Invest Dermatol. 2016 Feb;136(2):526-529
pubmed: 26967483